1 INTRODUCTION OF GLOBAL E-CLINICAL SOLUTIONS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL E-CLINICAL SOLUTIONS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 CLINICAL ANALYTICS PLATFORMS
5.3 CLINICAL DATA INTEGRATION PLATFORMS
5.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
5.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT
5.6 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)
5.7 ELECTRONIC TRIAL MASTER FILE (ETMF)
5.8 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)
5.9 SAFETY SOLUTIONS
6 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
6.1 OVERVIEW
6.2 CLOUD-BASED
6.3 LICENSED ENTERPRISE (ON-PREMISE)
6.4 WEB-HOSTED (ON-DEMAND)
7 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DEVELOPMENT PHASE
7.1 OVERVIEW
7.2 PHASE I
7.3 PHASE II
7.4 PHASE III
7.5 PHASE IV

8 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY END-USE
8.1 OVERVIEW
8.2 ACADEMIC INSTITUTES
8.3 CONTRACT RESEARCH ORGANIZATION (CROS)
8.4 HOSPITALS/HEALTHCARE PROVIDERS
8.5 MEDICAL DEVICE MANUFACTURERS
8.6 PHARMA & BIOTECH ORGANIZATIONS

9 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3. 1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE

9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL E-CLINICAL SOLUTIONS MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
11 COMPANY PROFILES
11.1 ANJU LIFE SCIENCES SOFTWARE
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 BIOCLINICA
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 CRF HEALTH
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 DASSAULT SYSTEMES
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 DATATRAK INTERNATIONAL, INC.
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 E-CLINICALWORKS
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.7 ERT CLINICAL
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.8. IBM
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.9 ORACLE
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.10 PAREXEL INTERNATIONAL CORPORATION
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS